Guntis Bahs

Guntis Bahs


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 January 2021 in Medicina
Verified
Journal Article
Open access
PDF file
JLJuris Guntis Lurins
Juris Guntis Lurins
Peteris TretjakovsPeteris Tretjakovs
Peteris Tretjakovs
SSSimons Svirskis
Simons Svirskis
GGGita Gersone
Gita Gersone
DHDace Hofmane
Dace Hofmane
VMVitolds Mackevics
Vitolds Mackevics
Background and Objectives: Aortic valve stenosis (AS) develops with a pronounced local inflammatory response, where a variety of growth factors are involved in the process, and may have a pro-inflammatory and anti-inflammatory effect. The aim of our study was to elucidate whether circulating growth factors: growth differentiation factor 15 (GDF-15), angiopoietin-2 (Ang-2), vascular endothelial growth factor A (VEGF-A), fibroblast growth factor 2 (FGF-2), and fibroblast growth factor 21 (FGF-21) could be proposed as clinically relevant biomarkers to improve risk stratification in AS patients. Materials and Methods: AS patients were classified into three groups: 16 patients with mild AS stenosis; 19 with moderate and 11 with severe AS, and 30 subjects without AS (echocardiographically approved) were selected as a control group. GDF-15, Ang-2, VEGF-A, FGF-2, and FGF-21 were measured in plasma by the ELISA method. Results: GDF-15 levels differed significantly not only when comparing AS patients with control groups (p < 0.0001), but also a statistically significant difference was achieved when comparing AS patients at a mild degree stage with control individuals. We found a strong relationship of GDF-15 levels regarding AS severity degree (p < 0.0001). VEGF-A, FGF-2 and FGF-21 levels were significantly higher in AS patients than in controls, but relationships regarding the AS severity degree were weaker (p < 0.02). ROC analysis of the study growth factors showed that GDF-15 might serve as a specific and sensitive biomarker of AS stenosis (AUC = 0.75, p = 0.0002). FGF-21 correlated with GDF-15, Ang-2, and FGF-2, but it did not reach the level to serve as a clinically relevant biomarker of AS stenosis. Conclusions: AS is associated with significantly increased GDF-15, VEGF-A, FGF-2, and FGF-21 levels in plasma, but only GDF-15 shows a pronounced relationship regarding AS severity degree, and GDF-15 might serve as a specific and sensitive biomarker of AS stenosis.

18 August 2021 in Biomedicines
Verified
Journal Article
Open access
PDF file
Peteris TretjakovsPeteris Tretjakovs
Peteris Tretjakovs
JLJuris Guntis Lurins
Juris Guntis Lurins
SSSimons Svirskis
Simons Svirskis
GGGita Gersone
Gita Gersone
DLDace Lurina
Dace Lurina
VMVitolds Mackevics
Vitolds Mackevics
Aortic valve stenosis (AS) develops not only with a pronounced local inflammatory response, but also oxidative stress is involved. The aim of this study was to evaluate the plasma levels of thioredoxin-1 (TRX1), myeloperoxidase (MPO), chemerin, growth differentiation factor 15 (GDF-15), angiopoietin-2 (Ang-2), vascular endothelial growth factor A (VEGF-A), fibroblast growth factor 2 (FGF-2), fibroblast growth factor 21 (FGF-21), and metalloproteinase (MMP)-1, -3, and -9 in acquired AS patients as well as to clarify the correlations of TXR1 and the plasma inflammatory biomarkers regarding AS severity. AS patients were classified into three groups: 16 patients with mild AS stenosis, 19 with moderate and 11 with severe AS, and 30 subjects without AS were selected as a control group. AS patients had significantly higher plasma levels of TRX1 compared to controls, but the highest difference was found in mild AS patients compared to the controls. We conclude that AS is associated with significantly increased plasma TRX1 levels, and TRX1 might serve as a specific and sensitive biomarker of AS. TRX1 and also chemerin, GDF-15, VEGF-A, FGF-2 and FGF-21 significantly correlate with AS severity degrees. TRX1 also showed positive association with FGF-2, VEGF-A, and MMP-3 in all AS patients.

26 September 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
APAelita Plinta
Aelita Plinta
Peteris TretjakovsPeteris Tretjakovs
Peteris Tretjakovs
SSSimons Svirskis
Simons Svirskis
ILInara Logina
Inara Logina
GGGita Gersone
Gita Gersone
GBGuntis Bahs
Guntis Bahs
The aim of the study was to clarify correlations between body mass index (BMI), blood pressure (BP), and serum levels of cytokines in female migraine patients. A total of 14 migraineurs with aura, and 12 without aura during their interictal period were compared with 25 controls. Interleukin-8 (IL-8), soluble intercellular adhesion molecule-1 (sICAM-1), soluble vascular cell adhesion molecule-1 (sVCAM-1), matrix metalloproteinase-9 (MMP-9), interferon gamma (IFN-γ), monocyte chemoattractant protein-1 (MCP-1), transforming growth factor alpha (TGF-α), and plasminogen activator inhibitor-1 (PAI-1) were measured. Migraineurs have elevated levels of IL-8, but decreased serum levels of PAI-1 and sICAM-1 during the interictal period, regardless of aura. BMI correlates with BP, and also with IFN-γ and MMP-9 only in patients with aura. There are three correlations in migraine patients with aura that are absent in patients without aura: between IL-8 and PAI-1; MMP-9 and IL-8; and IL-8 and sICAM-1. Migraineurs without aura, on the other hand, have correlations that patients with aura do not have (between PAI-1 and MCP-1, sICAM-1; between MMP-9 and sICAM-1, MCP-1; between TGF-α and PAI-1, MMP-9, sICAM-1; between sICAM-1 and MMP-9, PAI-1, MCP-1; as well as between sVCAM-1 and MCP-1). PAI-1, TGF, and MMP-9 could be used as biomarkers to distinguish migraineurs from healthy individuals.

3 September 2024 in European Conference on Knowledge Management
Verified
Journal Article
Open access
PDF file
EGEvita Grigorovica
Evita Grigorovica
ASAndreta Slavinska
Andreta Slavinska
GBGuntis Bahs
Guntis Bahs
In the 21st century, the healthcare sector faces formidable challenges, including the rapid proliferation of medical technology innovations, the extension of life expectancy, and the concurrent trend of ageing within society. Moreover, healthcare grapples with an acute shortage of workforce, accompanied by significant skills gaps and mismatches. The consequences of skills shortages, gaps, and mismatches are profound, potentially impeding the treatment process and compromising healthcare outcomes, thereby jeopardizing both the quality of healthcare and the safety of patients and healthcare professionals alike. These signals underscore the imperative for transformative adjustments within the healthcare sector. Amidst this dynamic landscape, healthcare institutions must cultivate systems and approaches capable of rapid adaptation to evolving circumstances while facilitating future planning and data-driven decision-making. Of paramount importance is the establishment of systems that ensure effective knowledge management for healthcare professionals, identify knowledge and skills gaps, and highlight improvement opportunities. In light of these exigencies, the authors have crafted a conceptual model of human capital management based on skills monitoring and tailored to the healthcare sector. This model encapsulates a human-centric management ethos, seamlessly integrated with a data-driven business strategy within a patient-centric healthcare paradigm. The practical implementation of the Human Capital Management Model would empower healthcare institutions to make informed, data-driven decisions to reach the strategic goals of the institution: ensuring efficient human resource provision with appropriate skill-mix, improving health quality, increasing patient and healthcare professional safety, and the sustainable use of financial resources.

8 July 2026 in Healthcare
Verified
Journal Article
Open access
PDF file
EGEvita Grigorovica
Evita Grigorovica
ASAndreta Slavinska
Andreta Slavinska
GBGuntis Bahs
Guntis Bahs
TMTatjana Muravska
Tatjana Muravska
Edgars EdelmersEdgars Edelmers
Edgars Edelmers
Background and Objectives: Health systems increasingly require workforce governance approaches that move beyond formal qualifications and make physician skills more visible for planning, education, quality management, and resource allocation. However, evidence remains limited on how physician skill information is organisationally documented and used within hospitals, particularly in small health systems. This study examined how information on physician skills is organisationally documented, interpreted, and used for workforce governance across all Latvian university hospitals, and identified organisational, cultural, and digital barriers to systematic skills monitoring. Materials and Methods: A qualitative, exploratory, multi-institutional design was adopted. Semi-structured interviews were conducted with 12 stakeholders from human resources, education, quality, and finance across all three Latvian university hospitals. Data were analysed using reflexive thematic analysis, with reporting guided by COREQ and SRQR. Results: Eight interrelated themes were identified across three domains. Current practices were fragmented and primarily focused on formal qualifications rather than verifiable practical skills. Internally delivered education was partially documented, whereas externally acquired skills remained largely outside organisational systems. Skill gaps were usually identified reactively through incidents, complaints, or managerial observation. Training needs were determined through decentralised channels, and skill assessment depended heavily on local leadership judgement. Participants also highlighted financial blind spots, weak digital infrastructure, governance ambiguity, cultural resistance, and limited staffing capacity as barriers to implementation. At the same time, respondents consistently reported that improved skill visibility could support strategic workforce planning, targeted education, patient safety, better financial justification, and greater organisational transparency. Conclusions: Latvian university hospitals appear to recognise the organisational value of physician skill visibility but currently lack integrated systems for capturing and using such information systematically. The findings support the need for a context-sensitive, phased approach to skills-based workforce governance and inform a data-informed conceptual framework (Three-Layer Skills Governance Model) for aligning regulatory expectations, organisational processes, and individual skill records in small health systems.